Sunday, January 6, 2019

The Bedaquiline conundrum: Why this TB drug is creating an intense debate

The Bedaquiline conundrum: Why this TB drug is creating an intense debate Bedaquiline, developed by Johnson Johnson (JJ), is used for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB)

from Moneycontrol Business News http://bit.ly/2Fcbnlk

No comments:

Post a Comment

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...